EO2463

Enterome · Phase 1 active Biologic

At a glance

Generic name	EO2463
Sponsor	Enterome
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

EO2463 CI brief — competitive landscape report
EO2463 updates RSS · CI watch RSS
Enterome portfolio CI